Fe(II)/α-ketoglutarate-dependent dioxygenases (Fe(II)/α-KG DOs) are powerful biocatalysts for C-H bond hydroxylation, generating diverse high-value mols.An inadequate cosubstrate α-KG supply leads to low yields of the desired products.Currently, -glutamate oxidase (LGOX) is used to generate α-KG and cascades with catalase (KatG) to eliminate H2O2 (a byproduct of LGOX), an inhibitor of Fe(II)/α-KG DOs.However, free enzymes still cause H2O2 accumulation, inhibiting Fe(II)/α-KG DO activity.Here, we employed RIAD-RIDD short peptides to form LGOX-KatG specific 1:2 ratio self-assembled tri-enzyme units using a scaffold-free strategy to obtain structural insights via computational anal. and to avoid H2O2 toxicity to achieve high yield of a promising anti-diabetic drug (2S,3R,4S)-4-hydroxyisoleucine in a one-pot system.A conversion of >95% was achieved at a 100 mM isoleucine within 7 h, with 2.00 g.L-1.h-1 space-time yield.This work provides a universal, industrially attractive approach for supplying a cosubstrate for Fe(II)/α-KG DO catalyzing hydroxylation.